Does interferon-free direct-acting antiviral therapy for hepatitis C after curative treatment for hepatocellular carcinoma lead to unexpected recurrences of HCC? A multicenter study by the Japanese Red Cross Hospital Liver Study Group.
Toshie MashibaKouji JokoMasayuki KurosakiHironori OchiYukio OsakiYuji KojimaRyo NakataTohru GotoAkahane TakehiroHiroyuki KimuraAkeri MitsudaChiharu KawanamiYasushi UchidaChikara OgawaAtsunori KusakabeRyuichi NaritaYasushi IdeTakehiko AbeKeiji TsujiTadashi KitamuraKazuhiko OkadaTetsuro SohdaMasaya ShigenoTakashi SatouNamiki IzumiPublished in: PloS one (2018)
There were no differences in the early recurrence rate of HCC between patients who underwent IFN and those who underwent IFN-free DAA as antiviral therapies.